Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 16.500 | 16.500 | 0.000 |
Shares | 87.230 | 87.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.018 | 24.691 |
Price to Book | 2.702 | 3.269 |
Price to Sales | 1.164 | 4.110 |
Price to Cash Flow | 11.074 | 17.419 |
Dividend Yield | 2.124 | 1.322 |
5 Years Earnings Growth | 19.661 | 18.917 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.440 | 97.322 |
Consumer Cyclical | 0.560 | 0.370 |
Number of long holdings: 31
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
WuXi AppTec | CNE1000031K4 | 8.85 | 45.78 | +4.83% | |
Chongqing Zhifei Bio Products | CNE100000V20 | 8.45 | 37.03 | +5.50% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 8.35 | 314.01 | +3.09% | |
Zhejiang Jiuzhou Pharm | CNE100001W36 | 6.62 | 16.60 | +2.98% | |
Jiangsu Hengrui | CNE0000014W7 | 6.07 | 47.16 | +2.17% | |
Jointown Pharm | CNE100000W45 | 5.79 | 8.35 | +1.71% | |
Humanwell Healthcare | CNE000000QW6 | 5.73 | 20.44 | +0.94% | |
Nhwa Pharma A | CNE100000CG8 | 4.93 | 25.50 | +1.96% | |
Kelun Pharm A | CNE100000PW7 | 3.95 | 33.97 | +0.06% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 3.76 | 25.08 | +4.59% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 562.55M | -14.26 | -7.09 | 7.49 | ||
MS Huaxin Resource Selected Mixed | 407.12M | 6.35 | -15.96 | 4.83 | ||
MS Huaxin Aggressive Growth Equity | 353.2M | -5.77 | -16.57 | - | ||
Huaxin Leading Advanced Stock | 300.41M | -8.05 | -5.93 | 9.27 | ||
Huaxin Excellent Growth Stock | 286.41M | -6.89 | -15.23 | 8.74 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review